Steven Cohen Precision Biosciences Inc Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $1.06 Million - $1.63 Million	-115,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $931,278 - $1.44 Million	115,400 New	115,400 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $1.53 Million - $3.19 Million	-255,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $1.19 Million - $2.23 Million	255,600 New	255,600 $1.57 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $1.08B
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.